Home›Calculators›Health›HAS-BLED Calculator

HAS-BLED Calculator

Health

Calculate the HAS-BLED score to estimate major bleeding risk in patients on anticoagulation, scoring hypertension, renal/liver function, stroke, and more.

Uncontrolled Hypertension (Systolic >160 mmHg)

Abnormal Renal Function (Dialysis, Transplant, or Cr >2.26 mg/dL)

Abnormal Liver Function (Cirrhosis, Bilirubin/Enzymes >2-3x Normal)

History of Stroke

Prior Major Bleeding or Bleeding Predisposition

Labile INR (Time in Therapeutic Range <60%)

Elderly (Age >65)

Concomitant Drugs (Antiplatelet Agents or NSAIDs)

Alcohol Excess (≥8 Drinks per Week)

HAS-BLED Score

0/ 9

Bleeding Risk Category

—

Not a substitute for clinical judgment. A high HAS-BLED score is a prompt for closer monitoring and correction of modifiable risk factors, not an automatic reason to stop anticoagulation — this decision must always be made with a qualified healthcare provider.

What is a HAS-BLED?

The HAS-BLED Calculator computes the HAS-BLED score, a validated clinical tool used to estimate the 1-year risk of major bleeding in patients on or being considered for anticoagulation therapy. The score sums points across nine criteria — hypertension, abnormal renal function, abnormal liver function, stroke history, bleeding history, labile INR, elderly age, and antiplatelet/NSAID use or alcohol excess — for a maximum of 9 points.

Select yes or no for each applicable criterion below to see your total score and bleeding risk category. For the corresponding stroke-risk tool used in the same clinical decision, see the CHA2DS2-VASc Calculator; for a related perioperative risk tool, see the Gupta Risk Calculator.

How to use this HAS-BLED calculator

  1. Select Yes or No for Uncontrolled Hypertension (Systolic >160 mmHg).
  2. Select Yes or No for Abnormal Renal Function.
  3. Select Yes or No for Abnormal Liver Function.
  4. Select Yes or No for History of Stroke.
  5. Select Yes or No for Prior Major Bleeding or Bleeding Predisposition.
  6. Select Yes or No for Labile INR.
  7. Select Yes or No for Elderly (Age >65).
  8. Select Yes or No for Concomitant Drugs (Antiplatelet Agents or NSAIDs).
  9. Select Yes or No for Alcohol Excess (≥8 Drinks per Week).
  10. Review your HAS-BLED Score and Bleeding Risk Category, and discuss the result with your physician before any anticoagulation decision.

Formula & Methodology

The HAS-BLED score sums the following points, each worth 1 point if present:

- Uncontrolled hypertension: 1 point
- Abnormal renal function: 1 point
- Abnormal liver function: 1 point
- History of stroke: 1 point
- Prior major bleeding or predisposition: 1 point
- Labile INR: 1 point
- Elderly (age >65): 1 point
- Antiplatelet agents or NSAIDs: 1 point
- Alcohol excess: 1 point

Total score = sum of all applicable points (maximum 9). A score of 0 is low risk, 1-2 is moderate risk, and ≥3 is high bleeding risk.

Worked example: A 70-year-old patient with uncontrolled hypertension and concurrent NSAID use scores: Elderly (1 point) + Hypertension (1 point) + Antiplatelet/NSAID use (1 point) = 3 points total, placing them in the high bleeding risk category per the original Pisters et al. 2010 (Chest) validation study, prompting closer monitoring rather than automatic discontinuation of anticoagulation.

Frequently Asked Questions

HAS-BLED is an acronym for the nine bleeding risk criteria it scores: Hypertension, Abnormal renal function, Abnormal liver function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly (over 65), and Drugs (antiplatelet agents or NSAIDs) or alcohol excess. Each applicable criterion adds 1 point toward a total out of 9.
It estimates the 1-year risk of major bleeding in patients being considered for or already taking anticoagulation, most commonly for atrial fibrillation. It's typically used alongside a stroke-risk score like CHA2DS2-VASc to weigh the tradeoff between stroke prevention and bleeding risk.
A score of 0 is generally considered low bleeding risk, 1-2 is moderate risk, and 3 or higher is considered high bleeding risk, warranting closer monitoring and correction of modifiable risk factors. These categories come from the original 2010 validation study.
No — a high HAS-BLED score is a signal to address modifiable risk factors (like uncontrolled blood pressure or labile INR) and monitor more closely, not an automatic reason to discontinue anticoagulation. Many high-scoring patients still benefit from anticoagulation once modifiable factors are managed, which is a decision your physician must make.
The 'A' in HAS-BLED covers two separate organ systems — abnormal renal function and abnormal liver function are scored independently, so a patient with both conditions receives 2 points from this category alone. The same logic applies to the 'D' category, where antiplatelet/NSAID use and alcohol excess can each independently add a point.
Labile INR generally refers to an unstable or unpredictable International Normalized Ratio in patients on warfarin, often defined as spending less than 60% of the time within the therapeutic range. It doesn't apply to patients on newer direct oral anticoagulants, which don't require routine INR monitoring.
HAS-BLED remains one of the most widely used and externally validated bleeding-risk scores, though some guidelines also reference newer tools like ORBIT or ABC-bleeding. Your physician may use one or more of these tools depending on local practice and patient factors.
No — this calculator is for informational and educational purposes only and simply reproduces the published HAS-BLED scoring system. Real anticoagulation decisions must weigh this score alongside stroke risk, patient preference, and clinical judgment from a qualified healthcare provider, never from this tool alone.
The HAS-BLED score was derived and validated by Pisters R, et al. and published in Chest, 2010;138(5):1093-1100, using a large cohort of atrial fibrillation patients on anticoagulation followed for major bleeding events over one year.
Stroke risk and bleeding risk are assessed with different tools because the same patient can be high risk for both — the [CHA2DS2-VASc Calculator](/cha2ds2-vasc-calculator/) estimates stroke risk, while HAS-BLED estimates bleeding risk, and clinicians weigh both together rather than using either alone.
HAS-BLED was validated specifically for ongoing anticoagulation management rather than perioperative planning; for surgery-specific cardiac risk, see the [Gupta Risk Calculator](/gupta-risk-calculator/), which addresses a different clinical question.
Discuss it with your physician, who can identify which specific modifiable factors (such as blood pressure control, concurrent NSAID use, or alcohol intake) are contributing most to your score and address them, rather than stopping anticoagulation outright.
Also known as
HAS-BLED score calculatoranticoagulation bleeding risk calculatormajor bleeding risk score calculatorAFib bleeding risk calculatorwarfarin bleeding risk calculator